Pomalidomide Market Manufacturing Base and Competitors Forecast 2021

Published on October 2017 | Categories: Science | Downloads: 100 | Comments: 0 | Views: 556
of 5
Download PDF   Embed   Report

Global Pomalidomide Market is segmented, by Dosage Forms & Strengths into 1mg, 2mg, 3mg, and 4mg. Pomalidomide is a small molecule analog of thalidomide under growth with Celgene company for the oral treatment of hematological and connective tissue diseases.

Comments

Content

Global Pomalidomide Market is segmented, by Dosage Forms & Strengths into 1mg, 2mg, 3mg, and 4mg. Pomalidomide is a small molecule analog of thalidomide under growth with Celgene company for the oral treatment of hematological and connective tissue diseases.

Sponsor Documents

Recommended


View All
Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close